Evidence map›Paper›PMID 20397961›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2010

Treatment to prevent transmission of HIV-1.

Myron S Cohen, Cynthia L Gay

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01764282 (A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission), which is not on this map. Cited by 93 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 4 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01764282 nacompletednot on this mapstarted 2012, after this paper: background citation

A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

TypeinterventionalSponsorNational Center for AIDS/STD Control and Prevention, China CDCRan2012 to 2015Enrolled11,096ConditionsHIVArmscomprehensive intervention components
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 4 syntheses or guidelines pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Prevention of HIV-1 infection with early antiretroviral therapy.The New England journal of medicine · 2011
    Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Myron S CohenUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030, USA. mscohen@med.unc.edu
Cynthia L Gay
University of North Carolina at Chapel Hill · US

Funding

HIV, TB, HSV 2--EMERGENCE OF DRUG RESISTANCER01AI041935 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BLOWER, SALLY MARGARET · 1998 to 2012
$6.6M
HIV IN SEMEN-EFFECTS OF STDS AND ANTIVIRAL THERAPYR37DK049381 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COHEN, MYRON SCOTT · 2005 to 2014
$3.4M
UNC CENTER FOR AIDS RESEARCHP30HD037260 · NICHD · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SWANSTROM, RONALD I · 1998 to 2000
$1.2M
NIAID NIH HHS R01 AI041935NIAID NIH HHS R01AI041935NICHD NIH HHS P30HD-37260NIDDK NIH HHS R37 DK049381NIDDK NIH HHS R37 DK49381
6 · The paper itself

Abstract

Antiretroviral therapy (ART) has the potential to prevent human immunodeficiency virus (HIV) transmission by reducing the concentration of HIV in blood and genital secretions. Indeed, mathematical models with favorable assumptions suggest the potential of ART to stop the spread of HIV infection. Empirical results from ecological and population-based studies and from several short-term observational studies involving HIV status-discordant heterosexual couples suggest that ART reduces the rate of HIV transmission. A multinational, randomized, controlled trial (National Institutes of Health HPTN052) examining the reliability and durability of ART as prevention of transmission in HIV status-discordant couples is under way. The latter and other studies also consider sexual risk-taking behavior and transmission of HIV-resistant variants when ART is used as prevention. Early HIV detection and treatment (ie, test and treat) are being considered as an important prevention strategy. In this article, we review the data supporting the use of ART to prevent HIV transmission and critically examine the public health implications of this strategy.

Indexed as

Anti-HIV AgentsDisease Transmission, InfectiousEarly DiagnosisHIV InfectionsHumansRandomized Controlled Trials as TopicAnti-HIV Agents

Identifiers

PMID20397961
PMCPMC4147719
OpenAlexW1972561651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.